BHP Shares Fall as Jansen Potash Project Costs Surge 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Trump Says Anthropic No Longer Seen as National Security Threat 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
NEW YORK, Jan. 12, 2016 - The Nasdaq Stock Market (“Nasdaq”) announced today that, pursuant to Listing Rule 5815(a)(1)(B), KaloBios Pharmaceuticals, Inc. (Nasdaq:KBIO) will be suspended from Nasdaq effective January 13, 2016.
Trading in the Company’s securities has been halted since December 17, 2015. The trading halt will no longer be in effect upon the suspension of KaloBios from Nasdaq, which would allow the Company’s securities to be eligible for trading in the over-the-counter markets under the symbol “KBIOQ.”
A hearing is scheduled for February 25, 2016, to review the company’s appeal of Nasdaq’s December 18, 2015 delist determination.
For news and additional information about the Company, including whether the Company’s securities will trade on another venue, please review the Company’s public filings or contact the Company directly.
For more information about Nasdaq trade halts, visit www.nasdaqtrader.com. For more information about the Nasdaq delisting process, visit listingcenter.nasdaq.com.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $8.8 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
